AZ launches branded YouTube channel, testimonial site

Share this article:

AstraZeneca (AZ) launched a branded YouTube channel today for its asthma drug Symbicort, as well as My Asthma Story (myasthmastory.com), a website calling for testimonial videos.

The YouTube channel and “vlog” (video blog) feature testimonial videos in widescreen, where patients describe their experiences with Symbicort. Some risk information scrolls across the bottom margin of the videos while they play, and a link to full PI information appears near the top of the channel page. Other fair balance information appears elsewhere on the page. The channel also directs consumers to myasthmastory.com, where Symbicort users are invited to upload videos about their own experiences with the drug.

According to Dana Settembrino, senior brand communications manager at AZ, the videos submitted on myasthmastory.com will be reviewed by a panel of legal, regulatory and compliance experts, with their selections appearing on the Symbicort YouTube channel.  Videos appearing on the YouTube channel are not open for comment by viewers.

The YouTube channel and the My Asthma Story website were created by Digitas and Cadient, and allow asthma-sufferers to “share patient stories about controlling asthma,” said Settembrino.  “[The channel and website] is a way to engage patients and maintain a conversation,” she said.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.